Stocks Top law firms involved in US opioid lawsuits set to receive hundreds of millions in fees By ReutersJune 7, 2024 Brendan Pearson (Reuters) – A court-appointed panel on Friday recommended splitting $2.13 billion in legal…
Stocks High doses of opioid reversal spray are no better than lower doses in the field, US study finds From ReutersFebruary 8, 2024 (Reuters) – A high-dose version of the opioid withdrawal spray naloxone made by Hikma Pharmaceuticals…
